These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11508771)

  • 21. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres.
    Kostanski JW; Thanoo BC; DeLuca PP
    Pharm Dev Technol; 2000; 5(4):585-96. PubMed ID: 11109259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.
    Allaoui-Attarki K; Pecquet S; Fattal E; Trollé S; Chachaty E; Couvreur P; Andremont A
    Infect Immun; 1997 Mar; 65(3):853-7. PubMed ID: 9038287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
    Uchida T; Goto S; Foster TP
    J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.
    Audran R; Peter K; Dannull J; Men Y; Scandella E; Groettrup M; Gander B; Corradin G
    Vaccine; 2003 Mar; 21(11-12):1250-5. PubMed ID: 12559806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres.
    Allaoui-Attarki K; Fattal E; Pecquet S; Trollé S; Chachaty E; Couvreur P; Andremont A
    Vaccine; 1998 Apr; 16(7):685-91. PubMed ID: 9562687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
    Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
    Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles.
    Kim SY; Doh HJ; Ahn JS; Ha YJ; Jang MH; Chung SI; Park HJ
    Vaccine; 1999 Feb; 17(6):607-16. PubMed ID: 10075169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres.
    Rojas J; Pinto-Alphandary H; Leo E; Pecquet S; Couvreur P; Fattal E
    Int J Pharm; 1999 Jun; 183(1):67-71. PubMed ID: 10361157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus E2 protein encapsulation into poly d, l-lactic-
    Roopngam P; Liu K; Mei L; Zheng Y; Zhu X; Tsai HI; Huang L
    Int J Nanomedicine; 2016; 11():5361-5370. PubMed ID: 27789948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique.
    Zhu KJ; Jiang HL; Du XY; Wang J; Xu WX; Liu SF
    J Microencapsul; 2001; 18(2):247-60. PubMed ID: 11253941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal or systemic administration of rE2 glycoprotein antigen loaded PLGA microspheres.
    Brandhonneur N; Loizel C; Chevanne F; Wakeley P; Jestin A; Le Potier MF; Le Corre P
    Int J Pharm; 2009 May; 373(1-2):16-23. PubMed ID: 19429284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
    Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
    J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres.
    Barman SP; Lunsford L; Chambers P; Hedley ML
    J Control Release; 2000 Dec; 69(3):337-44. PubMed ID: 11102674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
    Uchida T; Goto S
    Biol Pharm Bull; 1994 Sep; 17(9):1272-6. PubMed ID: 7841952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(D,L-lactide-co-glycolide) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system.
    Mandal TK; Bostanian LA; Graves RA; Chapman SR
    Pharm Res; 2002 Nov; 19(11):1713-9. PubMed ID: 12458678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres.
    Ravivarapu HB; Burton K; DeLuca PP
    Eur J Pharm Biopharm; 2000 Sep; 50(2):263-70. PubMed ID: 10962237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying.
    Quaglia F; De Rosa G; Granata E; Ungaro F; Fattal E; Immacolata La Rotonda M
    J Control Release; 2003 Jan; 86(2-3):267-78. PubMed ID: 12526823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
    Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
    Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles.
    Kabiri M; Sankian M; Sadri K; Tafaghodi M
    Eur J Pharm Biopharm; 2018 Dec; 133():321-330. PubMed ID: 30408519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines.
    Waeckerle-Men Y; Groettrup M
    Adv Drug Deliv Rev; 2005 Jan; 57(3):475-82. PubMed ID: 15560953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.